Changing trends in the surgical treatment of invasive XXXX .

@entity1 @entity957 @entity1442 @entity189
Twenty-nine years experience with 346 @entity1 with invasive @entity189 is presented. More than 90 per cent had @entity957 . The primary mode of treatment was surgical. Two hundred and ninety-six @entity1 were treated primarily with surgical treatment, 120 underwent radical vulvectomy and bilateral groin and pelvic lymphadenectomy, 133 had radical vulvectomy with bilateral groin dissection and 390 receiving nonradical procedures. Thirteen @entity1 had radical operations plus pelvic exenteration for @entity1442 . There were no intraoperative deaths, but 16 (5.4 per cent) died within 28 days of the operation. The uncorrected over-all five year survival rate was 66 per cent. In the presence of negative nodes, it was 83 per cent and with positive nodes, it was 38 per cent. Fifty per cent of those treated with exenteration are alive and disease-free at five years or more. Since one-third of the @entity1 presented with @entity1442 (Stages III and IV), earlier diagnosis and prompt referral must be encouraged to improve surgical results.
